RYAN NICKERSON: Open Payments
NPI 1578179503 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 52 payments from 26 companies in 2025. Trend: 2023 $895 · 2024 $712 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| SOBI, INC | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $60 |
| Astellas Pharma US Inc | 3 | $59 |
| PFIZER INC. | 3 | $58 |
| Geron Corporation | 2 | $53 |
| GENZYME CORPORATION | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
Products named: VENCLEXTA, Tazverik, IMBRUVICA, EPKINLY, Vonjo, Xospata, ELREXFIO, RYTELO.
Industry payments across CO — which companies pay providers there.
